Portal Biotech
Single-molecule proteomics
London, United Kingdom · Founded 2021 · $35.0M raised
- Headquarters
- London
- Founded
- 2021
- Business Model
- B2B
- Website
- portalbiotech.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Series AJun 2025
- Rounds
- 1
About
Portal Biotech develops bench-top solutions for comprehensive single-molecule protein sequencing and characterisation. Its nanopore technology detects and analyses individual molecules, producing electrical signatures that are decoded with machine-learning algorithms to reveal identity and sequence information. The company offers protein-characterisation services and is developing instruments for laboratories in academic research, biotechnology, biopharma, industrial settings, and service centres. Its platform supports analyses of small molecules, peptides, and full-length proteins.
Summary
Portal Biotech is a Biotech company based in London, United Kingdom, founded in 2021. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Jun 2025. Investors include NATO Innovation Fund, Earlybird Venture Capital and Pillar VC.
Funding History
Jun 2025
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/portal-biotech"><img src="https://indexed.vc/api/badge/company/portal-biotech" alt="Portal Biotech on Indexed.vc" width="260" height="76" /></a>